To investigate the effect of IL-28B on the TME and test whether IL-28B downregulating Tregs directly in vitro, rAd-mIL-28B was injected into H22 tumor-bearing mice and the effect of IL-28B on iTregs in vitro was also studied. This evidence concerns the gene IFNL3 and neoplasm.